业绩造假

Search documents
300237,将被ST!下周一停牌
Zhong Guo Ji Jin Bao· 2025-09-27 04:09
Core Viewpoint - Meicheng Technology faces administrative penalties due to false financial reporting, with a cumulative inflated revenue of 1.438 billion yuan and inflated profits of 658 million yuan from 2014 to 2018 [3][8][9]. Financial Misreporting - The company reported inflated revenues of 23.66 million yuan, 373 million yuan, 726 million yuan, 215 million yuan, and 101 million yuan for the years 2014 to 2018, respectively, accounting for 2.06%, 20.67%, 24.60%, 5.53%, and 2.88% of the disclosed revenue for those years [8]. - The inflated profits for the same years were 22.93 million yuan, 189 million yuan, 260 million yuan, 117 million yuan, and 69.49 million yuan, representing 17.91%, 75.64%, 49.78%, 15.49%, and 15.58% of the disclosed profit totals [8]. Regulatory Actions - The Shandong Securities Regulatory Bureau has proposed a fine of 600,000 yuan for the company and a total of 2.3 million yuan for 12 responsible individuals, including a 10-year market ban for Guo Baifeng, the former chairman of the subsidiary involved in the fraud [9][10]. - Starting September 30, the company's stock will be marked with a risk warning and will change its name to ST Meicheng, while the stock code remains the same [10][11]. Financial Performance - Meicheng Technology has reported continuous losses for four consecutive years from 2021 to 2024, with a total loss amounting to 3.683 billion yuan [12][13]. - The company attributes its ongoing losses primarily to declining performance in its landscaping business and difficulties in project payment collections [16]. Asset Disposal Strategy - To mitigate losses, Meicheng Technology is in the process of selling off its loss-making assets, particularly those related to the landscaping business [17]. - The company plans to divest 100% of its stake in the subsidiary, Saisiyuanlin, and has already initiated the transfer of several related companies [17]. Market Position - As of September 26, Meicheng Technology's stock closed at 3.22 yuan per share, with a market capitalization of 4.643 billion yuan [18].
深交所对京蓝科技及相关当事人给予公开谴责纪律处分
Mei Ri Jing Ji Xin Wen· 2025-08-15 13:15
Core Viewpoint - The Shenzhen Stock Exchange has publicly reprimanded Jinglan Technology Co., Ltd. and related parties for violations related to financial reporting and performance commitments [2][4]. Group 1: Violations and Disciplinary Actions - Jinglan Technology entered into an agreement in September 2018 to acquire 56.7152% of the shares of its subsidiary Zhongke Dingshi Environmental Engineering Co., Ltd. through a share issuance, with performance commitments to achieve a cumulative net profit of no less than 40 million yuan from 2018 to 2020 [2]. - In 2020, Zhongke Dingshi falsely recognized project completion and inflated revenue, costs, and profits to meet performance commitments, leading to significant misstatements in Jinglan Technology's annual report [3]. - The inflated figures included an increase in operating revenue by 162.91 million yuan (14.06% of reported revenue), operating costs by 96.55 million yuan (4.3% of reported costs), total profit by 66.36 million yuan (2.67% of total profit), and net profit by 57.71 million yuan (2.27% of net profit) [3]. Group 2: Disciplinary Measures - The Shenzhen Stock Exchange has decided to publicly reprimand Jinglan Technology and its former executives, including the chairman, president, vice president, and financial officer, for their roles in the violations [5]. - The disciplinary actions are based on the company's failure to adhere to the Stock Listing Rules and the lack of diligence and integrity from the executives involved [4][5]. - The company and the individuals have the right to apply for a review of the disciplinary decision within fifteen trading days [5].
许家印梦碎,中国恒大被港交所退市!两年虚增收入超过5600亿元,虚增利润超900亿元,昔日4000亿港元市值如今不足22亿
Jin Rong Jie· 2025-08-12 13:56
Core Viewpoint - China Evergrande Group has been delisted from the Hong Kong Stock Exchange due to failure to meet the resumption requirements, marking the end of its 16-year presence in the capital market [1] Financial Misconduct - China Evergrande inflated its revenue by over 560 billion yuan in 2019 and 2020, with a total of 564.15 billion yuan in inflated revenue and 92.01 billion yuan in inflated profits [2] - The former Vice Chairman and President, Xia Haijun, was fined 15 million yuan and banned for life from the securities market due to his role in the financial misconduct [2] Debt Situation - As of June 30, 2023, China Evergrande's total liabilities amounted to 2.39 trillion yuan, total assets were 1.74 trillion yuan, and net assets were -644.2 billion yuan, indicating a severe financial crisis [2] Legal and Operational Developments - The chairman, Xu Jiayin, has been taken into custody for suspected illegal activities, and former executives have also faced legal actions [3] - China Evergrande has filed for liquidation in Hong Kong, with the court ruling that only statutory creditors can participate in the liquidation process, excluding economic interest holders [4] Asset Management - The liquidators revealed that Evergrande has less than 10 billion HKD in overseas assets available for disposal, including shares in Evergrande Property and stakes in Evergrande Auto [4] - Legal actions have been initiated to recover 6 billion USD in dividends and salaries from former executives, including Xu Jiayin and his ex-wife [4] Market Valuation - Once valued at 400 billion HKD in 2017, China Evergrande's market capitalization has plummeted to approximately 2.15 billion HKD, reflecting a significant decline in investor confidence [6]
诺泰生物虚增业绩面临近5000万罚款,诺泰生物被ST
Di Yi Cai Jing· 2025-07-21 08:10
Core Viewpoint - NuoTai Bio has been penalized for financial misconduct, including inflating revenue and profits, leading to significant fines and a change in stock status to ST NuoTai [1][2] Group 1: Financial Misconduct - NuoTai Bio inflated its 2021 revenue by 30 million yuan and profit by 25.9516 million yuan, which accounted for 20.64% of the reported total profit for that year [1] - Despite the inflated figures, the company's actual performance showed a revenue increase of 13.58% to 644 million yuan, while net profit decreased by 6.52% to 115 million yuan [1] Group 2: Regulatory Actions and Penalties - The China Securities Regulatory Commission (CSRC) issued a total fine of 4.74 million yuan to NuoTai Bio for two main violations: information disclosure and fabrication of significant false content in public offering documents [2] - The actual controller of NuoTai Bio, Zhao Dezhong, was fined 18 million yuan, while other executives involved faced fines ranging from 1.5 million to 3.3 million yuan [2] Group 3: Stock Market Impact - Following the penalties, NuoTai Bio's stock was subjected to risk warnings and was suspended from trading, with its stock name changed to ST NuoTai starting July 22 [2]